z-logo
open-access-imgOpen Access
The role of anthracycline and pertuzumab in preoperative treatment of HER2-positive breast cancer
Author(s) -
Sylwia Dębska-Szmich,
Piotr Potemski
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2022.0012
Subject(s) - trastuzumab , pertuzumab , medicine , docetaxel , anthracycline , oncology , breast cancer , taxane , cancer , lapatinib

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom